Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sherwin-Williams (SHW)

Sherwin-Williams extends $ revolver to 2030 and adds $750 million delayed draw term loan

Neutral Impact 3 of 5 financing Written later

Sherwin-Williams amended its revolving credit agreement on August 8, 2025, extending the maturity from July 31, 2029 to August 8, 2030. The same day, it entered a new 364-day delayed draw term loan facility of $750 million in U.S. dollars and €250 million in euros, available until October 31, 2025, for general corporate purposes including working capital. The filing discloses no new earnings figures, but the added borrowing capacity and longer revolver maturity give the company more financing flexibility.

Key points

  • Revolver maturity extended from July 31, 2029 to August 8, 2030
  • New 364-day delayed draw term loan: $750 million (USD) and €250 million (EUR)
  • Delayed draw loans can be drawn in a single draw from August 8, 2025 through October 31, 2025
  • Financial covenant caps consolidated leverage ratio at 3.75 to 1.00, or 4.25 to 1.00 for four quarters after a Qualifying Acquisition

The filing

CompanySherwin-Williams (SHW)
Form8-K, current report
Filed with the SECAug 12, 2025, 7:30 AM ET
Accession number0001193125-25-178475

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 12, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.